Brief: Theranexus Cash And Cash Equivalents At 31 March 2018 At 16,172,000 Euros
15/05/2018 17:00
May 15 (Reuters) - THERANEXUS SA ALTHX.PA :
* CASH AND CASH EQUIVALENTS AT 31 MARCH 2018 AMOUNTED TO
€16,172,000 VERSUS €942,000 AT 31 MARCH 2017
Source text for Eikon: ID:nACT53312
Further company coverage: ALTHX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease